Taurine induces anti-anxiety by activating strychnine-sensitive glycine receptor in vivo

Annals of Nutrition and Metabolism

Volumn 51, Issue 4, 2007, Pages 379-386

  Zhang, Cheng Gao ^a,b   Kim, Sung Jin ^a  

^a Kyung Hee University   (South Korea)

^b YANBIAN UNIVERSITY   (China)

Author keywords

Anti anxiety; GABA receptor; Glycine receptor; Taurine

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; GLYCINE RECEPTOR; ISONIAZID; PICROTOXIN; STRYCHNINE; TAURINE; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CONVULSION; MALE; MAZE TEST; MEMORY; MOUSE; MUSCLE CONTRACTION; MUSCLE RELAXATION; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; ROTAROD TEST;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; AVOIDANCE LEARNING; EXERCISE TEST; EXPLORATORY BEHAVIOR; MALE; MAZE LEARNING; MICE; MICE, INBRED ICR; RANDOM ALLOCATION; RECEPTORS, GABA; RECEPTORS, GLYCINE; STRYCHNINE; TAURINE;

STRYCHNOS TOXIFERA;

EID: 34548814984     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107687     Document Type: Article

References (33)

1. Gupta RC, Kim SJ: Role of taurine in organs' dysfunction and in their alleviation. Crit Care Shock 2003; 6: 171-175.
2. Huxtable RJ (ed): The Biochemistry of Sulfur. New York, Plenum Press, 1986.
3. Huxtable RJ, Barbeau A (eds): Taurine. New York, Raven Press, 1976.
4. Huxtable RJ: Physiological actions of taurine. Physiol Rev 1992; 72: 101-163.
5. Sergeeva OA, Haas HL: Expression and function of glycine receptor in striatal cholinergic interneurons from rat and mouse. Neuroscience 2001; 104: 1043-1055.
6. Galarreta M, Bustamanta J, Martin DR: Taurine induces a long-lasting increase of synaptic efficacy and exon excitability in the hippocampus. J Neurosci 1996; 16: 92-102.
7. Lombardini JB: High-affinity uptake systems for taurine in tissue slices and central nervous system. Correction of transport data by different experimental procedures. J Neurochem 1977; 29: 305-312.
8. Sturman JA: Taurine in development. J Physiol Rev 1993; 73: 119-147.
9. Kuriyama K: Taurine as a neuromodulator. Fed Proc 1980; 39: 2680-2684.
10. Lin CT, Su YYT, Song GX, Wu JY: Is taurine a neurotransmitter in rabbit retina? Brain Res 1983; 337: 293-298.
11. Moran J, Solazar P, Pasantes-Morales H: Effect of tocopherol and taurine on membrane fluidity of retinal rod outer segments. Exp Eye Res 1988; 45: 769-776.
12. Birdsall TC: Therapeutic application of taurine. Altern Med Rev 1998; 3: 128-136.
13. El Idrissi AE, Messing J, Scalia J, Trenker E: Prevention of epileptic seizures by taurine. Adv Exp Med 2003;526: 515-525.
14. Chen SW, Kong WX, Zhang YJ, Li YL, Mi XJ, Mu XS: Possible anxiolytic effects of taurine in the mouse elevated plus maze. Life Sci 2004; 75: 1503-1511.
15. Kong WX, Chen SW, Li YL, Zhang YJ, Wang R, Min L, Mi X: Effects of taurine on rat behaviors in three anxiety models. Pharmacol Biochem Behav 2006; 83: 271-276.
16. Simiand J, Keane PE, Morre M: The staircase test in mice: a simple and efficient procedure for primary screening of anxiolytic agents. Psychopharmacology 1984; 84: 48-53.
17. Pellow S, Chopin PH, File SE, Briley M: Validation of open:closed entries in an elevated plus maze as a measure of anxiety in the rat. J Neurosci Methods 1985; 14: 149-167.
18. Bigler ED: Comparison of effects of bicuculline, strychnine, and picrotoxin with those of pentylenetetrazol on photically evoked after-discharges. Epilepsia 1977; 18: 465-470.
19. Usunoff G, Atsev E, Tchavdarov D: On the mechanism of picrotoxin epileptic seizure (macro- and microelectrode investigations). Electroencephalogr Clin Neurophysiol 1969; 27: 444-447.
20. Dunn R, Fielding S: Yohimbine-induced seizures in mice: a model predictive of potential anxiolytic and GABA-mimetic agents. Drug Dev Res 1987; 10: 177-188.
21. Costa E, Guidotti A, Mao CC: Evidence for involvement of GABA in the action of benzodiazepines: studies on rat cerebellum; in Costa E, Greengard P (eds): Mechanism of Action of Benzodiazepines. Advances in Biochemical Psychopharmacology. New York, Raven Press, 1975, vol 14, pp 113-151.
22. Tsuda M, Suzuki T, Misawa M, Nagase H: Involvement of the opioid in the anxiolytic effect of diazepam in mice. Eur J Pharmacol 1996; 307: 7-14.
23. Park CR, Seeley RJ, Craft S, Wood SC: Intracerebroventricular insulin enhances memory in a passive-avoidance task. Physiol Behav 2000; 68: 509-514.
24. Mohamed AF, Matsumoto K, Tabata K, Takayama H, Kitajima M, Aimi N, Watamabe H: Effects of Uncaria tomentosa total alkaloid and its components on experimental amnesia in mice: elucidation using the passive avoidance test. J Pharm Pharmacol 2000; 52: 1553-1561.
25. Huxtable RJ: Taurine in the central nervous sustain and the mammalian actions of taurine CNS. Neurobiology 1989; 32: 471-533.
26. Pericic D, Manev H, Bujas M: Gonadal hormones and picrotoxin-induced in male and female rat. Brain Res 1996; 14: 174-179.
27. - conductance of cerebellar Purkinje cell dendrites in vitro. Brain Res 1983; 259: 319-323.
28. B receptors in rat hippocampal CA1 area. Brain Res 2000; 864: 298-307.
29. 3H-strychnine as a ligand. J Neurosci 1990; 10: 795-813.
30. Lewis CA, Ahmed J, Faber DS: A characterization of glycinergic receptors present in cultured rat medullary neurons. J Neurophysiol 1991; 66: 1292-1303.
31. Schmieden V, Kuhse J, Bets H: Agonist pharmacology of neonatal and adult glycine receptor-α subunits: identification of amino acid residues involved in taurine activation. EMBO J 1992; 11: 2025-2032.
32. Rajendra S, Vandenberg RJ, Pierce KD: The unique extracellular disulfide loop of the glycine receptor is a principal ligand binding element. EMBO J 1995; 14: 2987-2998.
33. Xu H, Wang W, Tang ZQ, Xu TL, Chen L: Taurine acts as a glycine receptor agonist in slices of rat inferior collicus. Hear Res 2006; 220: 95-105.